FDA limits use of Stryker's Wingspan brain stents

Published date : 10 August 2012
Article date : 09 August 2012

The FDA has limited use of Stryker's Wingspan brain stent system to a narrower group of patients after studies suggested the device may increase stroke and death rates. 

The system's use is now restricted to those with recurrent stroke who, despite medical management, have not experienced new stroke symptoms within seven days before treatment with Wingspan.
 
The FDA notice included that, "While Wingspan is not beneficial for the broad population of stroke patients studied in SAMMPRIS there is evidence from the original HDE study to show there are probable benefits of using Wingspan to treat the specific population of patients outlined in the new indications for use."
 
As a result, Wingspan devices, approved in 2005, won't be recalled. 
 
Read more here
Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.